Company Search:
Advanced Search
Sponsored Links
Grape King Bio Ltd Company Snapshot
Grape King Bio Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grape King Bio Ltd with three other companies in this sector in Taiwan: Yungshin Global Holding Corp (2017 sales of 6.62 billion Taiwanese Dollars [US$221.86 million] of which 73% was Taiwan District), China Chemical and Pharmaceutical Company Limited (6.24 billion Taiwanese Dollars [US$209.20 million] of which 72% was Taiwan), and Lotus Pharmaceutical Co.,Ltd. (6.42 billion Taiwanese Dollars [US$215.20 million] of which 90% was Western Medicine Manufacture).

Sales Analysis. During the year ended December of 2017, sales at Grape King Bio Ltd were 9.39 billion Taiwanese Dollars (US$314.50 million). This is an increase of 2.2% versus 2016, when the company's sales were 9.19 billion Taiwanese Dollars. This was the fifth consecutive year of sales increases at Grape King Bio Ltd (and since 2012, sales have increased a total of 104%). Sales of Oem Department saw an increase that was more than double the company's growth rate: sales were up 50.8% in 2017, from 689.94 million Taiwanese Dollars to 1.04 billion Taiwanese Dollars. Not all segments of Grape King Bio Ltd experienced an increase in sales in 2017: sales of Distribution Sector fell 8.7% to 297.46 million Taiwanese Dollars. (However, this segment's sales were only a very small portion of the company's overall sales). Grape King Bio Ltd also experienced decreases in sales in Direct Sales (down 1.5% to 8.05 billion Taiwanese Dollars) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Grape King Bio Ltd
  Stock Performance Chart for Grape King Bio Ltd
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 232.50
(Figures in Taiwanese Dollars)
1 Week -3.3%   13 Weeks -14.4%  
4 Weeks 16.3%   52 Weeks 25.0%  
Grape King Bio Ltd Key Data:
  Ticker: 1707 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 9,388,128,000
(Year Ending Jan 2018).
Employees: 501
  Currency: Taiwanese Dollars Market Cap: 31,405,774,500
  Fiscal Yr Ends: December Shares Outstanding: 135,078,600
  Share Type: Common Closely Held Shares: 26,157,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.